What Researchers Did
Researchers repeatedly measured lung flow-volume and spirometry before, during, and after continuous oxygen exposures at 1.5, 2.0, and 2.5 ATA for average durations of 17.7, 9.0, and 5.7 hours, respectively.
What They Found
They found that rates of pulmonary symptom development and lung volume reduction increased progressively with higher oxygen pressures, specifically at 1.5, 2.0, and 2.5 ATA. Average rates of vital capacity reduction provided a general description of pulmonary oxygen tolerance in humans, with exposures lasting 17.7, 9.0, and 5.7 hours, respectively.
What This Means for Canadian Patients
Canadian patients undergoing prolonged oxygen therapy or engaging in activities like diving should be aware of the potential for pulmonary oxygen toxicity. Monitoring for symptoms like lung volume reduction and respiratory distress is important to mitigate risks associated with extended high-pressure oxygen exposure.
Canadian Relevance
This study has no direct Canadian connection, as it was not conducted in Canada nor involved Canadian researchers or participants.
Study Limitations
The study acknowledges that individual variations and complex interactions of oxygen toxicity effects mean deviations from average relationships may occur in different individuals or conditions.